DURACLON
CLONIDINE HYDROCHLORIDE
Approval overview DURACLON is listed in Drugs@FDA under application 020615 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient CLONIDINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 5MG/10ML (0.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor MYLAN INSTITUTIONAL Submission history Latest submission status date: 2016-08-01 00:00:00.
Structured Monograph
Clinical summary
Approval overview DURACLON is listed in Drugs@FDA under application 020615 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CLONIDINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 5MG/10ML (0.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor MYLAN INSTITUTIONAL Submission history Latest submission status date: 2016-08-01 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.